Heart failure: preventing disease and death worldwide

Area of Science:

• Cardiology
• Public Health
• Health Policy

Background:

• Heart failure (HF) is a critical global health issue with a poor prognosis, impacting over 26 million people worldwide.
• HF presents significant challenges to patients, caregivers, and healthcare systems, with increasing demands predicted due to demographic and lifestyle changes.
• Despite its preventability and the availability of lifestyle interventions, public awareness of HF remains low, leading to premature deaths.

Purpose of the Study:

• To highlight the urgent need for policy initiatives to prioritize heart failure (HF) prevention and ensure equitable care.
• To advocate for increased public and professional awareness regarding HF symptoms, risk factors, and management.
• To emphasize the importance of research and improved clinical practice guideline adherence for better HF outcomes.

Main Methods:

• Policy recommendations focusing on public awareness campaigns and professional education.
• Strategies for ensuring equitable access to timely diagnosis, treatment, and long-term management of HF.
• Emphasis on patient and caregiver empowerment through education and support resources.
• Call for increased funding and international collaboration in HF research, including new therapies and performance measures.

Main Results:

• Implementing public awareness programs can significantly improve recognition of HF symptoms and promote prevention through healthy lifestyles.
• Enhanced education for healthcare professionals can improve HF prevention, diagnosis, treatment, and management.
• Ensuring equitable access to care and supporting patients/caregivers empowers them in managing HF.
• Policy-level changes and research are essential to address unmet needs and improve global HF outcomes.

Conclusions:

• Policy interventions are vital to elevate heart failure (HF) as a global health priority, focusing on prevention, awareness, and equitable care.
• Strengthening healthcare systems, empowering patients, and fostering research are key to reducing the burden of HF.
• International collaboration and targeted research are essential for developing new, affordable therapies and effective management strategies for HF worldwide.